Bluespine, a New York-based provider of an AI-driven claims cost reduction platform for self-insured employers, has secured $7.2 million in seed funding.
Investors
The round was led by Team8, with participation from strategic partners.
Team8 is a global venture creation and venture capital fund focused on building and investing in companies across cybersecurity, data & AI, fintech, and digital health sectors. Team8 supports startups from inception to growth, offering specialized expertise in technology, go-to-market strategies, HR, and business operations to enhance their success.
Bluespine Use of Funds
The funding will drive Bluespine’s adoption by U.S. employers and brokers, enhance R&D efforts, and support team expansion.
About Bluespine
Founded in 2023 by David Talinovsky, Gal Frishman, and Yossi Mansano, Bluespine provides an AI-driven claims cost reduction solution that empowers self-insured employers to lower annual healthcare spending while mitigating financial and legal risks around plan administration. Its mission is to reduce wasteful healthcare spending and empower companies to serve their employees' health needs better. Headquartered in Manhattan, they serve Fortune 500 companies and other large self-insured employers, healthcare brokers, and auditors.
Funding Details
Company: Bluespine, Inc.
Raised: $7.2M
Round: Seed Round
Funding Date: November 2024
Lead Investor: Team8
Additional Investors: Strategic Partners
Company Website: https://www.bluespine.io/
Software Category: Claims Cost Reduction Solution
Source: https://www.prnewswire.com/news-releases/bluespine-raises-7-2-million-in-seed-funding-to-help-self-insured-employers-tackle-medical-overbilling-302304287.html